Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU (ASPIRE-ICU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02413242

Recruitment Status : Completed

First Posted : April 9, 2015

Last Update Posted : May 8, 2019

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

MedImmune LLC

Universiteit Antwerpen

Information provided by (Responsible Party):

Jan Kluytmans, UMC Utrecht

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	April 30, 2019
Actual Study Completion Date :	April 30, 2019

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Paling FP, Troeman DPR, Wolkewitz M, Kalyani R, Prins DR, Weber S, Lammens C, Timbermont L, Goossens H, Malhotra-Kumar S, Sifakis F, Bonten MJM, Kluytmans JAJW. Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU. BMC Infect Dis. 2017 Sep 25;17(1):643. doi: 10.1186/s12879-017-2739-4.

To Top